UBS Maintains a 'Buy' on Triumph Group (TGI); Guiding Above The Street
Get Alerts TGI Hot Sheet
Price: $26.01 --0%
Rating Summary:
7 Buy, 12 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
7 Buy, 12 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
UBS maintains a 'Buy' on Triumph Group (NYSE: TGI) price target raised from $70 to $74.
Analyst, David E. Strauss, said, "Q4 at $1.57 ex $0.50 pension curtailment gain and $0.03 AIT costs, above our estimate at $1.30 and Street at $1.31...Initial FY13 EPS guidance at $5.45-5.55 on $3.5-3.7B in revenues (3-9% y/y growth) along with mid 14% operating margins. We estimate that guidance implies expectation for roughly 22% incremental margins after adjusting for $2M increase in legal expenses and $16M benefit from higher pension income and lower OPEB expense.
For an analyst ratings summary and ratings history on Triumph Group click here. For more ratings news on Triumph Group click here.
Shares of Triumph Group closed at $63.41 yesterday.
Analyst, David E. Strauss, said, "Q4 at $1.57 ex $0.50 pension curtailment gain and $0.03 AIT costs, above our estimate at $1.30 and Street at $1.31...Initial FY13 EPS guidance at $5.45-5.55 on $3.5-3.7B in revenues (3-9% y/y growth) along with mid 14% operating margins. We estimate that guidance implies expectation for roughly 22% incremental margins after adjusting for $2M increase in legal expenses and $16M benefit from higher pension income and lower OPEB expense.
For an analyst ratings summary and ratings history on Triumph Group click here. For more ratings news on Triumph Group click here.
Shares of Triumph Group closed at $63.41 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Hims and Hers (HIMS) PT Lowered to $35 at Barclays
- Deutsche Bank Upgrades Target Hospitality (TH) to Buy
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share